802 articles
A newly discovered bacteriophage inside common gut bacteria appears strongly linked to colorectal cancer, potentially explaining a long-standing medical paradox.
A small phase I trial found nivolumab injected into oral precancers shrank lesions in 85% of patients, offering a non-surgical alternative.
A low-dose three-drug pill slashed recurrent stroke risk and improved blood pressure control in intracerebral hemorrhage survivors, a major RCT found.
A surprising study found young lung cancer patients ate healthier diets, but experts warn against misreading the data.
Satralizumab slashed relapses in MOGAD by 68% in the first-ever positive RCT for this demyelinating disease.
Two major trials show Paxlovid doesn't reduce hospitalization or death in vaccinated COVID patients, though it may speed recovery.
A China-based clinical trial shows gene therapy gave significant hearing improvement to 90% of participants, including some adults.
The AACR 2026 conference spotlights emerging cancer therapeutics — from targeted therapies to immunotherapy advances — with direct implications for longevity.
A common immune marker in standard blood tests may predict dementia risk long before cognitive decline begins, a large NYU study finds.
BioAge's oral drug BGE-102 dramatically reduced hsCRP and IL-6 in obese participants with elevated inflammation, with a strong safety profile.
Insilico Medicine assembles top scientists and a Nobel laureate to guide AI-driven aging research and translate longevity compounds into real medicines.
Tozorakimab significantly reduced dangerous COPD exacerbations in 1,454 patients, marking a third pivotal trial success for this novel biologic.
